A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia

Clinical trial NCT05345938 · TERMINATED

Trial details

NCT number: NCT05345938
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Acute Myeloid Leukemia (AML)

Start date: 2022-06-14
Primary completion: 2022-11-19
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.